• Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join a Project
    • All Projects
    • Chemical Safety Library Project
    • Clinical Trial Environmental Impact
    • DataFAIRy Bioassay Annotation Project
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Social Media & Real-World Evidence
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Diversity & Inclusion Leadership Program
    • Controlled Substance Compliance
    • Lab of the Future
    • Quantum Computing
    • User Experience for Life Sciences
  • New Ideas
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
  • Training
    • All Training Events
    • Past Webinars
  • News

  • Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join a Project
    • All Projects
    • Chemical Safety Library Project
    • Clinical Trial Environmental Impact
    • DataFAIRy Bioassay Annotation Project
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Social Media & Real-World Evidence
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Diversity & Inclusion Leadership Program
    • Controlled Substance Compliance
    • Lab of the Future
    • Quantum Computing
    • User Experience for Life Sciences
  • New Ideas
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
  • Training
    • All Training Events
    • Past Webinars
  • News
Submit A New Idea Become a Member
Search

Search...

  • Menu

The Pistoia Alliance Collaborate to Innovate Conference promises to be the biggest yet!

A comprehensive agenda, with over 20 global speakers, join us on the 18th April 2023, in London.

With the support from our sponsors and members, we have been able to create one of the largest conferences in the Pistoia Alliance’s history.

Each sponsor has brought something new to the day, with the view to sharing their latest developments within the wider Pharma community.

 

 

Accenture 

Accenture’s purpose is to deliver on the promise of technology and human ingenuity. Learn more: www.accenture.com/lifesciences

 

BIOVIA

BIOVIA, Dassault Systèmes supports science-based industries by providing a scientific collaborative environment for advanced biological, chemical and materials experiences. BIOVIA solutions including molecular modelling & simulation, data science, scientific and laboratory informatics, formulation design, quality & compliance and manufacturing analytics are used by more than 2,000 companies globally.

 

CAS

CAS is a leader in scientific information solutions, partnering with global innovators to accelerate breakthroughs by curating, connecting, and analyzing the world’s scientific knowledge. Connect with us at cas.org.

 

CDD

Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD helps scientists register entities, track inventory, manage assay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world.  

Learn more at www.collaborativedrug.com

 

Optibrium

Optibrium develops cutting-edge software for small molecule design, optimisation and data analysis. Their lead product, StarDrop™, is a comprehensive suite of integrated software that enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research. Cerella™, Optibrium’s proven AI software, guides successful drug discovery, generating valuable insights from your compound data.

Optibrium was founded in 2009 in Cambridge, UK, with a US subsidiary, Optibrium Inc., in Cambridge, MA. The company works with over 180 customers and collaborators, including leading global pharma, biotech, agrochemical companies and academic groups.

 

Seqera Labs

Seqera Labs is the leading provider of workflow orchestration and collaborative data analysis software for the global life sciences community. Thousands of organizations trust Seqera Labs to provision and manage large-scale computational pipelines, boost productivity, reduce cost and complexity, and simplify regulatory compliance. As the creator of open-source Nextflow and Tower, Seqera Labs is on a mission to deliver a seamless user experience and help organizations scale their critical operations. Seqera Lab’s products are used for some of the most important work on the planet, including developing personalized immunogenic vaccines, new diagnostics, ML-based image processing, and pathogenic surveillance. For more information on Seqera Labs, visit http://seqera.io or follow the company at @Seqeralabs.

 

Strateos

Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. 

The Strateos™ Platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.

 

 

Vitality Technet

Our vision is to leverage the power of technology to create a more connected, informed, and sustainable world. As a company, we are committed to responsible and ethical data practices that prioritize data privacy, security, and transparency. We strive to bridge the gap between local vernacular and regulatory compliant semantic standards, creating a unified data landscape that drives value and innovation for our customers. We believe that by putting the needs of our customers and stakeholders first, we can drive positive change and create a world where data is accessible, interoperable, and reusable. Together, we can build a better future for all.

Last Updated on April 11, 2023 by Catherine Maskell
Categories: Blog, Pistoia Alliance News


Events

29 Nov 2023 - 30 Nov 2023

BIO-IT World Conference & Expo Europe

Book this event >
29 Nov 2023 - 30 Nov 2023

Bio-IT World Conference & Expo Europe

Book this event >
05 Dec 2023

CCDC Webinar: How Rapid Assessment of Molecular Geometries Can Help the Structure-Based Drug Designer

Book this event >
08 Dec 2023

FAIR (meta) – Data & Assay Annotation

Book this event >
Follow Us
Submit A New Idea Become a Member
Featured Projects
Clinical Trial Environmental Impact Project
Natural Language Processing (NLP) Use Case Database Project
IDMP Ontology Project
Unified Integrated Knowledge Base
Microbiome Project
Data Visualization Project
Methods Hub Project
Informed Consent Blockchain Project
Quality Generation and Ethical Use of Digital Health Data in Clinical Studies
Semantic Enrichment of ELN Data Project (SEED)
Sign up for Pistoia Alliance Communications

© Copyright Pistoia Alliance, Inc., 2023 | Contact us at info@pistoiaalliance.org | Terms of use | Privacy Statement

By clicking "Agree" you are agreeing to the following terms and conditions for the use of the UDM XML Schema definition.

This website intends to use cookies to improve the site and provide you with a better browsing experience. If you select "Continue" or continue to browse the site without customizing your choices, you agree to our use of cookies. Find out more in our Online Privacy Statement.

Continue More Info